Arthur Morgan, who has spinal muscular atrophy (SMA), received the one-off US gene therapy, Zolgensma, last week.
Arthur Morgan, who has spinal muscular atrophy (SMA), received the one-off US gene therapy, Zolgensma, last week.
Editor's note: Thomas Pogge is a Leitner Professor of Philosophy and International Affairs at Yale University. Peggy Tse is an Investment Specialist in the International Finance Corporation of the
简体中文
